Previous clinical studies that involved administration of high dose corticosteroids, platelet activation factor receptor antagonists, and anti-endotoxin therapy had shown promise in patients with sepsis due to Gram-negative organisms, but no significant effect on infections with Gram-positive bacteria [42]. This evidence concerns the gene PTAFR and Sepsis.